On Tuesday, Jasper Therapeutics Inc (NASDAQ: JSPR) opened higher 8.26% from the last session, before settling in for the closing price of $5.45. Price fluctuations for JSPR have ranged from $3.13 to $26.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -7.44% at the time writing. With a float of $12.59 million, this company’s outstanding shares have now reached $15.02 million.
The firm has a total of 64 workers. Let’s measure their productivity. In terms of profitability, gross margin is 24.53%, operating margin of -7067.21%, and the pretax margin is 1169.34%.
Jasper Therapeutics Inc (JSPR) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Jasper Therapeutics Inc is 16.21%, while institutional ownership is 74.03%. The most recent insider transaction that took place on Dec 12 ’24, was worth 19,899. In this transaction Chief Operating Officer of this company sold 900 shares at a rate of $22.11, taking the stock ownership to the 25,009 shares. Before that another transaction happened on Dec 12 ’24, when Company’s Executive Officer proposed sale 900 for $22.47, making the entire transaction worth $20,223.
Jasper Therapeutics Inc (JSPR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.68% during the next five years compared to 54.53% growth over the previous five years of trading.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Check out the current performance indicators for Jasper Therapeutics Inc (JSPR). In the past quarter, the stock posted a quick ratio of 4.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.25, a number that is poised to hit -1.33 in the next quarter and is forecasted to reach -5.01 in one year’s time.
Technical Analysis of Jasper Therapeutics Inc (JSPR)
Analysing the last 5-days average volume posted by the [Jasper Therapeutics Inc, JSPR], we can find that recorded value of 0.37 million was lower than the volume posted last year of 0.4 million. As of the previous 9 days, the stock’s Stochastic %D was 72.56%. Additionally, its Average True Range was 0.44.
During the past 100 days, Jasper Therapeutics Inc’s (JSPR) raw stochastic average was set at 41.97%, which indicates a significant decrease from 81.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.39% in the past 14 days, which was lower than the 167.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.66, while its 200-day Moving Average is $12.92. Now, the first resistance to watch is $6.25. This is followed by the second major resistance level at $6.59. The third major resistance level sits at $6.99. If the price goes on to break the first support level at $5.51, it is likely to go to the next support level at $5.11. Now, if the price goes above the second support level, the third support stands at $4.77.
Jasper Therapeutics Inc (NASDAQ: JSPR) Key Stats
There are currently 15,022K shares outstanding in the company with a market cap of 88.63 million. Presently, the company’s annual sales total 0 K according to its annual income of -71,270 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -21,240 K.
